Back

Do female patients with hypertrophic cardiomyopathy have a worse prognosis than male patients?

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Insights in hypertrophic cardiomyopathy and Chagas‘ disease Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Veronika Puchnerova

Motol University Hospital, Prague (Czechia)

7 More presentations in this session

Presentation thumbnail
Ventricular activation time as a marker for complex ventricular arrhythmias, sudden cardiac death and ICD implantation in hypertrophic cardiomyopathy
Doctor K. Fragkiadakis (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Predictors of left ventricular dysfunction in hypertrophic cardiomyopathy: results from a nationwide registry
Doctor M. Brandao (Madrid, ES)
Abstract Slides
Presentation thumbnail
Exercise unmasks impaired vascular and cardiac hemodynamic in patients with hypertrophic cardiomyopathy
Doctor M. Tamargo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Genotype-phenotype correlation and allele dating analysis of a novel variant in hypertrophic cardiomyopathy: p.Arg652Lys in MYH7
Mr G. Antoniutti (Palma de Mallorca, ES)
Abstract Slides
Presentation thumbnail
The impact of adrenoceptor-1 gene polymorphism on structural and functional features in patients with hypertrophic cardiomyopathy
Doctor D. Raimoglou (Istanbul, TR)
Abstract Slides

Access the full session

Session thumbnail
Insights in hypertrophic cardiomyopathy and Chagas‘ disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources